You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

venetoclax

( veh-NEH-toh-klax )
Funding:
Exceptional Access Program
  • Treatment of chronic lymphocytic leukemia/small lymphocytic lymphoma according to clinical criteria.
Other Name(s): Venclexta®
Appearance: tablet in various strengths and colours

You might also be interested in